An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer

An invasion front gene expression signature for higher-risk patient selection in stage IIA MSS colon cancer

Stage II colon cancer (CC) encompasses a heterogeneous group of patients with diverse survival experiences: 87% to 58% 5-year relative survival rates for stages IIA and IIC, respectively. While stage IIA patients are usually spared the adjuvant chemotherapy, some of them relapse and may benefit from...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Eva Budinská, Martina Čarnogurská, Tina Catela Ivković, Táňa Macháčková, Marie Boudná, Lucie Pifková, Ondřej Slabý, Beatrix Bencsiková, Vlad Popovici
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Frontiers Media S.A. 2024-04-01
Loạt:Frontiers in Oncology
Những chủ đề:
colon cancer
invasion front
early stage
prognostic signature
stage II/MSS
Truy cập trực tuyến:https://www.frontiersin.org/articles/10.3389/fonc.2024.1367231/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2024.1367231/full

Những quyển sách tương tự